CVRx (CVRX) Competitors $7.80 +0.23 (+3.04%) Closing price 08/22/2025 04:00 PM EasternExtended Trading$7.63 -0.17 (-2.18%) As of 08/22/2025 06:06 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock CVRX vs. KMTS, EMBC, SIBN, BBNX, AXGN, BVS, SMLR, ZIMV, AVNS, and KIDSShould you be buying CVRx stock or one of its competitors? The main competitors of CVRx include Kestra Medical Technologies (KMTS), Embecta (EMBC), SiBone (SIBN), Beta Bionics (BBNX), AxoGen (AXGN), Bioventus (BVS), Semler Scientific (SMLR), ZimVie (ZIMV), AVANOS MEDICAL (AVNS), and OrthoPediatrics (KIDS). These companies are all part of the "medical equipment" industry. CVRx vs. Its Competitors Kestra Medical Technologies Embecta SiBone Beta Bionics AxoGen Bioventus Semler Scientific ZimVie AVANOS MEDICAL OrthoPediatrics CVRx (NASDAQ:CVRX) and Kestra Medical Technologies (NASDAQ:KMTS) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their media sentiment, institutional ownership, earnings, profitability, analyst recommendations, dividends, valuation and risk. Do institutionals & insiders believe in CVRX or KMTS? 75.3% of CVRx shares are held by institutional investors. 13.9% of CVRx shares are held by company insiders. Comparatively, 3.6% of Kestra Medical Technologies shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term. Does the media favor CVRX or KMTS? In the previous week, CVRx had 2 more articles in the media than Kestra Medical Technologies. MarketBeat recorded 2 mentions for CVRx and 0 mentions for Kestra Medical Technologies. CVRx's average media sentiment score of 1.48 beat Kestra Medical Technologies' score of 0.00 indicating that CVRx is being referred to more favorably in the media. Company Overall Sentiment CVRx Positive Kestra Medical Technologies Neutral Which has preferable valuation and earnings, CVRX or KMTS? CVRx has higher earnings, but lower revenue than Kestra Medical Technologies. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCVRx$51.29M3.98-$59.97M-$2.10-3.71Kestra Medical Technologies$59.81M15.95-$113.81MN/AN/A Do analysts rate CVRX or KMTS? CVRx presently has a consensus price target of $14.00, indicating a potential upside of 79.49%. Kestra Medical Technologies has a consensus price target of $27.33, indicating a potential upside of 47.11%. Given CVRx's stronger consensus rating and higher probable upside, analysts clearly believe CVRx is more favorable than Kestra Medical Technologies.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score CVRx 1 Sell rating(s) 0 Hold rating(s) 5 Buy rating(s) 1 Strong Buy rating(s) 2.86Kestra Medical Technologies 0 Sell rating(s) 1 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 2.83 Is CVRX or KMTS more profitable? Kestra Medical Technologies has a net margin of 0.00% compared to CVRx's net margin of -95.61%. Kestra Medical Technologies' return on equity of 0.00% beat CVRx's return on equity.Company Net Margins Return on Equity Return on Assets CVRx-95.61% -79.31% -40.96% Kestra Medical Technologies N/A N/A N/A SummaryCVRx beats Kestra Medical Technologies on 8 of the 13 factors compared between the two stocks. Get CVRx News Delivered to You Automatically Sign up to receive the latest news and ratings for CVRX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding CVRX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CVRX vs. The Competition Export to ExcelMetricCVRxMED INSTRUMENTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$197.97M$6.88B$5.76B$9.58BDividend YieldN/A1.31%4.41%4.10%P/E Ratio-3.7127.4531.1026.04Price / Sales3.9875.51433.45102.77Price / CashN/A21.3437.7358.48Price / Book3.516.889.536.61Net Income-$59.97M$176.42M$3.26B$265.56M7 Day Performance10.95%1.45%2.10%1.97%1 Month Performance-9.30%-2.71%2.81%-0.36%1 Year Performance-10.65%9.40%30.56%19.03% CVRx Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CVRXCVRx2.5882 of 5 stars$7.80+3.0%$14.00+79.5%-6.5%$197.97M$51.29M-3.71160KMTSKestra Medical TechnologiesN/A$14.65+0.9%$27.33+86.6%N/A$745.58M$59.81M0.00300EMBCEmbecta4.8382 of 5 stars$12.73+3.7%$19.00+49.3%+9.0%$717.67M$1.12B8.902,100Positive NewsHigh Trading VolumeSIBNSiBone4.1755 of 5 stars$15.40-1.8%$23.67+53.7%+10.0%$676.45M$167.18M-27.50350News CoverageInsider TradeBBNXBeta Bionics2.6296 of 5 stars$14.30-3.0%$22.56+57.7%N/A$640.75M$65.12M0.00294News CoveragePositive NewsInsider TradeAXGNAxoGen3.017 of 5 stars$14.01+0.8%$26.00+85.6%+31.7%$639.58M$187.34M-140.09450Short Interest ↑BVSBioventusN/A$6.93+0.1%$13.75+98.4%-22.7%$569.26M$564.14M-11.361,200SMLRSemler Scientific3.4863 of 5 stars$35.28-2.4%$81.75+131.7%+11.0%$534.89M$56.29M14.52120Positive NewsZIMVZimVie0.7047 of 5 stars$18.83+0.1%$17.75-5.7%+11.2%$530.46M$449.75M-26.901,770Positive NewsShort Interest ↑AVNSAVANOS MEDICAL3.2926 of 5 stars$10.52-2.8%N/A-49.6%$502.08M$687.80M-1.042,227Short Interest ↑KIDSOrthoPediatrics3.9369 of 5 stars$18.81-0.5%$34.14+81.5%-32.9%$474.14M$204.73M-10.51200 Related Companies and Tools Related Companies KMTS Competitors EMBC Competitors SIBN Competitors BBNX Competitors AXGN Competitors BVS Competitors SMLR Competitors ZIMV Competitors AVNS Competitors KIDS Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:CVRX) was last updated on 8/23/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredThe $7 company helping Nvidia build the world’s first trillion-dollar robot …Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profit...Weiss Ratings | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CVRx, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share CVRx With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access